Search results
Results from the WOW.Com Content Network
The “2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation” provides recommendations to guide clinicians in the treatment of patients with atrial fibrillation. METHODS
The purpose of this document is to update the “2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation” S1.3-1 (2014 AF Guideline) in areas for which new evidence has emerged since its publication. The scope of this focused update of the 2014 AF Guideline includes revisions to the section on anticoagulation ...
recommendations addressing atrial fibrillation and thromboembolic risk assessment, anticoagulation, left atrial appendage occlusion, atrial fibrillation catheter or surgical ablation, and risk factor modification and atrial fibrillation prevention have been developed.
Test your in-depth knowledge of this guideline with CME, CE and MOC educational activities. Use these for critical decision making at the point-of-care. JACC Atrial Fibrillation Guideline Interactive Tool. JACC Central Illustration: Management Strategies for New Classification of Atrial Fibrillation. Increase patient knowledge and motivation ...
The 3 selected messages are focused on the new stages of atrial fibrillation (take-home message 1), the importance of early rhythm control (take-home message 5), and the use of catheter ablation as first-line therapy in select patients (take-home message 6).
The following are key perspectives from the 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation (AF): The current guideline's classification of AF focuses on the stages of AF including the pre-detection period.
Overview. The 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation (ACC/AHA/ACCP/HRS Atrial Fibrillation Guideline) provides guidance for clinicians on the management of patients with atarial fibrillation (AF).
In addition, new recommendations addressing atrial fibrillation and thromboembolic risk assessment, anticoagulation, left atrial appendage occlusion, atrial fibrillation catheter or surgical ablation, and risk factor modification and atrial fibrillation prevention have been developed.
This comprehensive document updates the recommendations from the 2014 and 2019 guidelines on atrial fibrillation and includes new recommendations on atrial fibrillation and thromboembolic risk assessment, anticoagulation, left atrial appendage occlusion, atrial fibrillation catheter or surgical ablation, and risk factor modification and atrial f...
The newest clinical guideline released by the ACC and the American Heart Association (AHA) provides new and updated recommendations for preventing and optimally managing atrial fibrillation (AFib).